Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitazyme P is an oral liquid digestive aid formulation developed by East India Pharmaceutical Works. It contains a combination of fungal diastase (an amylolytic enzyme) and pepsin (a proteolytic enzyme). Fungal diastase assists in the digestion of complex carbohydrates and starches by hydrolyzing them into simpler sugars like maltose, while pepsin breaks down dietary proteins into smaller peptides and amino acids. This combination is indicated for the relief of indigestion, bloating, flatulence, and abdominal discomfort, particularly in conditions such as long-standing diabetes, long-term proton pump inhibitor (PPI) use, stress, pregnancy, convalescence, and in elderly patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fungal diastase + pepsin (East India Pharmaceutical Works).